Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
01 2023
Historique:
received: 12 08 2022
accepted: 18 01 2023
revised: 02 02 2023
pubmed: 24 1 2023
medline: 7 2 2023
entrez: 23 1 2023
Statut: epublish

Résumé

Coronavirus disease 2019 is a respiratory infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Evidence on the pathogenesis of SARS-CoV-2 is accumulating rapidly. In addition to structural proteins such as Spike and Envelope, the functional roles of non-structural and accessory proteins in regulating viral life cycle and host immune responses remain to be understood. Here, we show that open reading frame 8 (ORF8) acts as messenger for inter-cellular communication between alveolar epithelial cells and macrophages during SARS-CoV-2 infection. Mechanistically, ORF8 is a secretory protein that can be secreted by infected epithelial cells via both conventional and unconventional secretory pathways. Conventionally secreted ORF8 is glycosylated and loses the ability to recognize interleukin 17 receptor A of macrophages, possibly due to the steric hindrance imposed by N-glycosylation at Asn78. However, unconventionally secreted ORF8 does not undergo glycosylation without experiencing the ER-Golgi trafficking, thereby activating the downstream NF-κB signaling pathway and facilitating a burst of cytokine release. Furthermore, we show that ORF8 deletion in SARS-CoV-2 attenuates inflammation and yields less lung lesions in hamsters. Our data collectively highlights a role of ORF8 protein in the development of cytokine storms during SARS-CoV-2 infection.

Identifiants

pubmed: 36689483
doi: 10.1371/journal.ppat.1011128
pii: PPATHOGENS-D-22-01407
pmc: PMC9894554
doi:

Substances chimiques

ORF8 protein, SARS-CoV-2 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011128

Informations de copyright

Copyright: © 2023 Lin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Viruses. 2022 Feb 21;14(2):
pubmed: 35216034
Cell Death Dis. 2021 Jan 12;12(1):71
pubmed: 33436558
Int J Mol Sci. 2021 Nov 08;22(21):
pubmed: 34769490
mBio. 2018 Feb 6;9(1):
pubmed: 29437924
Cell Host Microbe. 2021 Dec 8;29(12):1788-1801.e6
pubmed: 34822776
mBio. 2020 Oct 20;11(5):
pubmed: 33082264
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
PLoS One. 2012;7(11):e49224
pubmed: 23133677
Proc Natl Acad Sci U S A. 2021 Jan 12;118(2):
pubmed: 33361333
Int J Mol Sci. 2021 Oct 02;22(19):
pubmed: 34639046
Am J Respir Crit Care Med. 2009 Sep 15;180(6):521-32
pubmed: 19590023
Nature. 2020 Dec;588(7838):498-502
pubmed: 32805734
Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749
pubmed: 33087899
Nature. 2021 Apr;592(7852):116-121
pubmed: 33106671
Sci Rep. 2018 Oct 11;8(1):15177
pubmed: 30310104
Mol Metab. 2021 Nov;53:101296
pubmed: 34271220
Front Immunol. 2021 Jun 23;12:683800
pubmed: 34248968
Shock. 2021 Nov 1;56(5):667-672
pubmed: 34652339
Biomol Ther (Seoul). 2021 May 1;29(3):273-281
pubmed: 33504682
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Cell Res. 2021 Oct;31(10):1123-1125
pubmed: 34341488
Nat Immunol. 2020 Oct;21(10):1293-1301
pubmed: 32807944
Dev Cell. 2021 Dec 6;56(23):3250-3263.e5
pubmed: 34706264
Sci Adv. 2021 Dec 03;7(49):eabk0172
pubmed: 34851677
Nat Commun. 2021 May 11;12(1):2672
pubmed: 33976130
mBio. 2022 Apr 26;13(2):e0040222
pubmed: 35343786
Hepatology. 2022 Feb;75(2):438-454
pubmed: 34580902
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):
pubmed: 34021074
J Biol Chem. 2022 Mar;298(3):101724
pubmed: 35157849
EMBO J. 2013 Jun 12;32(12):1660-4
pubmed: 23665917
Trends Biochem Sci. 2020 Dec;45(12):1065-1079
pubmed: 32893104
PLoS Pathog. 2019 Jul 25;15(7):e1007907
pubmed: 31344124
Cell Host Microbe. 2020 May 13;27(5):841-848.e3
pubmed: 32289263
Int Immunol. 2023 Jan 21;35(1):43-52
pubmed: 36053553
iScience. 2021 Apr 23;24(4):102293
pubmed: 33723527
J Virol. 2020 May 18;94(11):
pubmed: 32161171
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
Mol Cell Proteomics. 2021;20:100058
pubmed: 33077685
Trends Cell Biol. 2019 Dec;29(12):940-953
pubmed: 31630879
Elife. 2013 Aug 06;2:e00947
pubmed: 23930225
Natl Sci Rev. 2020 Jun;7(6):1012-1023
pubmed: 34676127
EMBO Rep. 2021 Sep 6;22(9):e52252
pubmed: 34288348
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet. 2020 Aug 29;396(10251):603-611
pubmed: 32822564
Front Immunol. 2014 Oct 27;5:538
pubmed: 25386181
Signal Transduct Target Ther. 2021 Jul 7;6(1):255
pubmed: 34234112
Am J Respir Cell Mol Biol. 1996 Apr;14(4):309-15
pubmed: 8600933
J Biol Chem. 2021 Oct;297(4):101227
pubmed: 34562451
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Semin Cell Dev Biol. 2018 Nov;83:3-7
pubmed: 29458182
J Infect Dis. 2021 Aug 2;224(3):395-406
pubmed: 33493287
Front Immunol. 2021 Oct 04;12:741502
pubmed: 34671355
Cell Mol Immunol. 2020 Aug;17(8):881-883
pubmed: 32555321
JCI Insight. 2020 Sep 3;5(17):
pubmed: 32687484
Curr Opin Struct Biol. 2017 Jun;44:125-133
pubmed: 28363124
Front Microbiol. 2017 Jul 25;8:1415
pubmed: 28791003
Cell Rep. 2021 Mar 30;34(13):108916
pubmed: 33765414
Nat Rev Mol Cell Biol. 2012 Jun 22;13(7):448-62
pubmed: 22722607

Auteurs

Xiaoyuan Lin (X)

School of Life Sciences, Chongqing University, Chongqing, China.
Institut für Virologie, Freie Universität Berlin, Berlin, Germany.

Beibei Fu (B)

School of Life Sciences, Chongqing University, Chongqing, China.

Yan Xiong (Y)

School of Life Sciences, Chongqing University, Chongqing, China.

Na Xing (N)

Institut für Virologie, Freie Universität Berlin, Berlin, Germany.

Weiwei Xue (W)

School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.

Dong Guo (D)

School of Life Sciences, Chongqing University, Chongqing, China.

Mohamed Zaky (M)

Molecular Physiology Division, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.

Krishna Pavani (K)

Department of Reproduction, Obstetrics and Herd Health, Ghent University, Merelbeke, Belgium.

Dusan Kunec (D)

Institut für Virologie, Freie Universität Berlin, Berlin, Germany.

Jakob Trimpert (J)

Institut für Virologie, Freie Universität Berlin, Berlin, Germany.

Haibo Wu (H)

School of Life Sciences, Chongqing University, Chongqing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH